PUBLISHER: KBV Research | PRODUCT CODE: 1405232
PUBLISHER: KBV Research | PRODUCT CODE: 1405232
North America Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030
The North America Antibody Therapeutics Market would witness market growth of 13.7% CAGR during the forecast period (2023-2030).
The safety profile of antibody therapeutics represents a compelling factor in their adoption. The targeted nature of antibodies minimizes off-target effects and reduces the risk of adverse events. This attribute is especially crucial in chronic conditions or diseases that require long-term treatment, where maintaining a favorable safety profile is paramount to ensuring patient compliance and overall well-being. Antibody therapeutics align seamlessly with this ethos, allowing for the customization of therapies based on patient-specific factors. The ability to engineer antibodies for specific targets or patient populations enhancses treatment precision and response rates, contributing to the growing adoption of personalized therapeutic strategies.
Continuous advancements in antibody engineering and discovery technologies contribute to the expanding adoption of these therapeutics. Innovations such as phage display, hybridoma technology, and computational approaches have streamlined the development process, enabling the rapid identification and optimization of antibody candidates. This acceleration in drug development timelines aligns with the growing demand for efficient and effective therapeutic solutions. Antibody therapeutics play a pivotal role in the field of oncology. Monoclonal antibodies (mAbs) are designed to specifically target and bind to cancer cells or proteins associated with cancer growth. These antibodies can be tailored to inhibit critical signaling pathways for cancer cell survival, mark cancer cells for immune system destruction, or deliver cytotoxic agents directly to cancer cells. Examples include Rituximab, Trastuzumab, and Pembrolizumab, which have demonstrated efficacy in treating various cancers.
Rare diseases are incredibly diverse, encompassing various conditions that vary in their symptoms, underlying causes, and clinical manifestations in the US. Advances in medical research and diagnostic capabilities have led to the identification of new rare diseases in the US. The expansion of rare diseases has led to increased clinical trial activity focused on developing and testing antibody therapeutics in the US. Ongoing biotechnology and antibody engineering advancements have expanded the capabilities of developing targeted therapeutics in the US. As per a report by the US Food & Drug Administration updated in 2022, in the US, more than 30 million people suffer from more than 7,000 rare diseases. Due to the above-mentioned factors, the antibody therapeutics market will grow significantly in this region.
The US market dominated the North America Antibody Therapeutics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $165,924.2 million by 2030. The Canada market is experiencing a CAGR of 16.3% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 15.2% during (2023 - 2030).
Based on Route of Administration, the market is segmented into Intravenous, Subcutaneous, and Others. Based on Format, the market is segmented into, Monoclonal Antibody, Polyclonal Antibody Therapy, Bispecific Antibody, Antibody fragment & Others. Based on Source, the market is segmented into Human, Humanized, and Chimeric. Based on End User, the market is segmented into Hospitals, Long-term care facilities, and Others. Based on Disease Areas, the market is segmented into Autoimmune & Inflammatory Diseases, Neurology, Osteology, Hematology, Oncology, Infectious Diseases, Immunology, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd, AbbVie, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Merck KGaA, Bristol Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., Novartis AG, Biogen, Inc. and Amgen, Inc.
Scope of the Study
Market Segments covered in the Report:
By Route of Administration
- Intravenous
- Subcutaneous
- Others
By Format
- Monoclonal Antibody
- Polyclonal Antibody Therapy
- Bispecific Antibody
- Antibody fragment & Others
By Source
- Human
- Humanized
- Chimeric
By End User
- Hospitals
- Long-term care facilities
- Other
By Disease Areas
- Autoimmune & Inflammatory Diseases
- Neurology
- Osteology
- Hematology
- Oncology
- Infectious Diseases
- Immunology
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- F. Hoffmann-La Roche Ltd
- AbbVie, Inc.
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Merck KGaA
- Bristol Myers Squibb Company
- AstraZeneca PLC
- Sanofi S.A.
- Novartis AG
- Biogen, Inc.
- Amgen, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Antibody Therapeutics Market, by Route of Administration
- 1.4.2 North America Antibody Therapeutics Market, by Format
- 1.4.3 North America Antibody Therapeutics Market, by Source
- 1.4.4 North America Antibody Therapeutics Market, by End User
- 1.4.5 North America Antibody Therapeutics Market, by Disease Areas
- 1.4.6 North America Antibody Therapeutics Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Antibody Therapeutics market.
Chapter 5. North America Antibody Therapeutics Market by Route of Administration
- 5.1 North America Intravenous Market by Country
- 5.2 North America Subcutaneous Market by Country
- 5.3 North America Others Market by Country
Chapter 6. North America Antibody Therapeutics Market by Format
- 6.1 North America Monoclonal Antibody Market by Country
- 6.2 North America Polyclonal Antibody Therapy Market by Country
- 6.3 North America Bispecific Antibody Market by Country
- 6.4 North America Antibody fragment & Others Market by Country
Chapter 7. North America Antibody Therapeutics Market by Source
- 7.1 North America Human Market by Country
- 7.2 North America Humanized Market by Country
- 7.3 North America Chimeric Market by Country
- 7.4 North America Others Market by Country
Chapter 8. North America Antibody Therapeutics Market by End User
- 8.1 North America Hospitals Market by Country
- 8.2 North America Long-term care facilities Market by Country
- 8.3 North America Others Market by Country
Chapter 9. North America Antibody Therapeutics Market by Disease Areas
- 9.1 North America Autoimmune & Inflammatory Diseases Market by Country
- 9.2 North America Neurology Market by Country
- 9.3 North America Osteology Market by Country
- 9.4 North America Hematology Market by Country
- 9.5 North America Oncology Market by Country
- 9.6 North America Infectious Diseases Market by Country
- 9.7 North America Immunology Market by Country
- 9.8 North America Others Market by Country
Chapter 10. North America Antibody Therapeutics Market by Country
- 10.1 US Antibody Therapeutics Market
- 10.1.1 US Antibody Therapeutics Market by Route of Administration
- 10.1.2 US Antibody Therapeutics Market by Format
- 10.1.3 US Antibody Therapeutics Market by Source
- 10.1.4 US Antibody Therapeutics Market by End User
- 10.1.5 US Antibody Therapeutics Market by Disease Areas
- 10.2 Canada Antibody Therapeutics Market
- 10.2.1 Canada Antibody Therapeutics Market by Route of Administration
- 10.2.2 Canada Antibody Therapeutics Market by Format
- 10.2.3 Canada Antibody Therapeutics Market by Source
- 10.2.4 Canada Antibody Therapeutics Market by End User
- 10.2.5 Canada Antibody Therapeutics Market by Disease Areas
- 10.3 Mexico Antibody Therapeutics Market
- 10.3.1 Mexico Antibody Therapeutics Market by Route of Administration
- 10.3.2 Mexico Antibody Therapeutics Market by Format
- 10.3.3 Mexico Antibody Therapeutics Market by Source
- 10.3.4 Mexico Antibody Therapeutics Market by End User
- 10.3.5 Mexico Antibody Therapeutics Market by Disease Areas
- 10.4 Rest of North America Antibody Therapeutics Market
- 10.4.1 Rest of North America Antibody Therapeutics Market by Route of Administration
- 10.4.2 Rest of North America Antibody Therapeutics Market by Format
- 10.4.3 Rest of North America Antibody Therapeutics Market by Source
- 10.4.4 Rest of North America Antibody Therapeutics Market by End User
- 10.4.5 Rest of North America Antibody Therapeutics Market by Disease Areas
Chapter 11. Company Profiles
- 11.1 F. Hoffmann-La Roche Ltd.
- 11.1.1 Company Overview
- 11.1.2 Financial Analysis
- 11.1.3 Segmental and Regional Analysis
- 11.1.4 Research & Development Expense
- 11.1.5 Recent strategies and developments:
- 11.1.5.1 Partnerships, Collaborations, and Agreements:
- 11.1.5.2 Product Launches and Product Expansions:
- 11.1.6 SWOT Analysis
- 11.2 AbbVie, Inc.
- 11.2.1 Company Overview
- 11.2.2 Financial Analysis
- 11.2.3 Regional Analysis
- 11.2.4 Research & Development Expense
- 11.2.5 Recent strategies and developments:
- 11.2.5.1 Partnerships, Collaborations, and Agreements:
- 11.2.5.2 Acquisition and Mergers:
- 11.2.6 SWOT Analysis
- 11.3 Johnson & Johnson (Johnson & Johnson Services, Inc.)
- 11.3.1 Company Overview
- 11.3.2 Financial Analysis
- 11.3.3 Segmental &Regional Analysis
- 11.3.4 Research & Development Expenses
- 11.3.5 Recent strategies and developments:
- 11.3.5.1 Partnerships, Collaborations, and Agreements:
- 11.3.6 SWOT Analysis
- 11.4 Merck KGaA
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Segmental and Regional Analysis
- 11.4.4 Research & Development Expense
- 11.4.5 Recent strategies and developments:
- 11.4.5.1 Partnerships, Collaborations, and Agreements:
- 11.4.6 SWOT Analysis
- 11.5 Bristol Myers Squibb Company
- 11.5.1 Company Overview
- 11.5.2 Financial Analysis
- 11.5.3 Regional Analysis
- 11.5.4 Research & Development Expenses
- 11.5.5 Recent strategies and developments:
- 11.5.5.1 Acquisition and Mergers:
- 11.5.6 SWOT Analysis
- 11.6 AstraZeneca PLC
- 11.6.1 Company Overview
- 11.6.2 Financial Analysis
- 11.6.3 Regional Analysis
- 11.6.4 Research & Development Expenses
- 11.6.5 SWOT Analysis
- 11.7 Sanofi S.A.
- 11.7.1 Company Overview
- 11.7.2 Financial Analysis
- 11.7.3 Segmental and Regional Analysis
- 11.7.4 Research & Development Expense
- 11.7.5 SWOT Analysis
- 11.8 Novartis AG
- 11.8.1 Company Overview
- 11.8.2 Financial Analysis
- 11.8.3 Segmental and Regional Analysis
- 11.8.4 Research & Development Expense
- 11.8.5 SWOT Analysis
- 11.9 Biogen, Inc.
- 11.9.1 Company Overview
- 11.9.2 Financial Analysis
- 11.9.3 Regional Analysis
- 11.9.4 Research & Development Expense
- 11.9.5 SWOT Analysis
- 11.10. Amgen, Inc.
- 11.10.1 Company Overview
- 11.10.2 Financial Analysis
- 11.10.3 Regional Analysis
- 11.10.4 Research & Development Expenses
- 11.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 North America Antibody Therapeutics Market, 2019 - 2022, USD Million
- TABLE 2 North America Antibody Therapeutics Market, 2023 - 2030, USD Million
- TABLE 3 North America Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
- TABLE 4 North America Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
- TABLE 5 North America Intravenous Market by Country, 2019 - 2022, USD Million
- TABLE 6 North America Intravenous Market by Country, 2023 - 2030, USD Million
- TABLE 7 North America Subcutaneous Market by Country, 2019 - 2022, USD Million
- TABLE 8 North America Subcutaneous Market by Country, 2023 - 2030, USD Million
- TABLE 9 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 10 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 11 North America Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
- TABLE 12 North America Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
- TABLE 13 North America Monoclonal Antibody Market by Country, 2019 - 2022, USD Million
- TABLE 14 North America Monoclonal Antibody Market by Country, 2023 - 2030, USD Million
- TABLE 15 North America Polyclonal Antibody Therapy Market by Country, 2019 - 2022, USD Million
- TABLE 16 North America Polyclonal Antibody Therapy Market by Country, 2023 - 2030, USD Million
- TABLE 17 North America Bispecific Antibody Market by Country, 2019 - 2022, USD Million
- TABLE 18 North America Bispecific Antibody Market by Country, 2023 - 2030, USD Million
- TABLE 19 North America Antibody fragment & Others Market by Country, 2019 - 2022, USD Million
- TABLE 20 North America Antibody fragment & Others Market by Country, 2023 - 2030, USD Million
- TABLE 21 North America Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
- TABLE 22 North America Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
- TABLE 23 North America Human Market by Country, 2019 - 2022, USD Million
- TABLE 24 North America Human Market by Country, 2023 - 2030, USD Million
- TABLE 25 North America Humanized Market by Country, 2019 - 2022, USD Million
- TABLE 26 North America Humanized Market by Country, 2023 - 2030, USD Million
- TABLE 27 North America Chimeric Market by Country, 2019 - 2022, USD Million
- TABLE 28 North America Chimeric Market by Country, 2023 - 2030, USD Million
- TABLE 29 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 30 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 31 North America Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
- TABLE 32 North America Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
- TABLE 33 North America Hospitals Market by Country, 2019 - 2022, USD Million
- TABLE 34 North America Hospitals Market by Country, 2023 - 2030, USD Million
- TABLE 35 North America Long-term care facilities Market by Country, 2019 - 2022, USD Million
- TABLE 36 North America Long-term care facilities Market by Country, 2023 - 2030, USD Million
- TABLE 37 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 38 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 39 North America Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
- TABLE 40 North America Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
- TABLE 41 North America Autoimmune & Inflammatory Diseases Market by Country, 2019 - 2022, USD Million
- TABLE 42 North America Autoimmune & Inflammatory Diseases Market by Country, 2023 - 2030, USD Million
- TABLE 43 North America Neurology Market by Country, 2019 - 2022, USD Million
- TABLE 44 North America Neurology Market by Country, 2023 - 2030, USD Million
- TABLE 45 North America Osteology Market by Country, 2019 - 2022, USD Million
- TABLE 46 North America Osteology Market by Country, 2023 - 2030, USD Million
- TABLE 47 North America Hematology Market by Country, 2019 - 2022, USD Million
- TABLE 48 North America Hematology Market by Country, 2023 - 2030, USD Million
- TABLE 49 North America Oncology Market by Country, 2019 - 2022, USD Million
- TABLE 50 North America Oncology Market by Country, 2023 - 2030, USD Million
- TABLE 51 North America Infectious Diseases Market by Country, 2019 - 2022, USD Million
- TABLE 52 North America Infectious Diseases Market by Country, 2023 - 2030, USD Million
- TABLE 53 North America Immunology Market by Country, 2019 - 2022, USD Million
- TABLE 54 North America Immunology Market by Country, 2023 - 2030, USD Million
- TABLE 55 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 56 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 57 North America Antibody Therapeutics Market by Country, 2019 - 2022, USD Million
- TABLE 58 North America Antibody Therapeutics Market by Country, 2023 - 2030, USD Million
- TABLE 59 US Antibody Therapeutics Market, 2019 - 2022, USD Million
- TABLE 60 US Antibody Therapeutics Market, 2023 - 2030, USD Million
- TABLE 61 US Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
- TABLE 62 US Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
- TABLE 63 US Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
- TABLE 64 US Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
- TABLE 65 US Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
- TABLE 66 US Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
- TABLE 67 US Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
- TABLE 68 US Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
- TABLE 69 US Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
- TABLE 70 US Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
- TABLE 71 Canada Antibody Therapeutics Market, 2019 - 2022, USD Million
- TABLE 72 Canada Antibody Therapeutics Market, 2023 - 2030, USD Million
- TABLE 73 Canada Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
- TABLE 74 Canada Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
- TABLE 75 Canada Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
- TABLE 76 Canada Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
- TABLE 77 Canada Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
- TABLE 78 Canada Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
- TABLE 79 Canada Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
- TABLE 80 Canada Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
- TABLE 81 Canada Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
- TABLE 82 Canada Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
- TABLE 83 Mexico Antibody Therapeutics Market, 2019 - 2022, USD Million
- TABLE 84 Mexico Antibody Therapeutics Market, 2023 - 2030, USD Million
- TABLE 85 Mexico Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
- TABLE 86 Mexico Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
- TABLE 87 Mexico Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
- TABLE 88 Mexico Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
- TABLE 89 Mexico Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
- TABLE 90 Mexico Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
- TABLE 91 Mexico Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
- TABLE 92 Mexico Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
- TABLE 93 Mexico Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
- TABLE 94 Mexico Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
- TABLE 95 Rest of North America Antibody Therapeutics Market, 2019 - 2022, USD Million
- TABLE 96 Rest of North America Antibody Therapeutics Market, 2023 - 2030, USD Million
- TABLE 97 Rest of North America Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
- TABLE 98 Rest of North America Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
- TABLE 99 Rest of North America Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
- TABLE 100 Rest of North America Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
- TABLE 101 Rest of North America Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
- TABLE 102 Rest of North America Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
- TABLE 103 Rest of North America Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
- TABLE 104 Rest of North America Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
- TABLE 105 Rest of North America Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
- TABLE 106 Rest of North America Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
- TABLE 107 Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 108 Key information - AbbVie, Inc.
- TABLE 109 Key Information - Johnson & Johnson
- TABLE 110 key Information - Merck KGaA
- TABLE 111 Key Information - Bristol Myers Squibb Company
- TABLE 112 KEY INFORMATION - AstraZeneca PLC
- TABLE 113 Key Information - Sanofi S.A.
- TABLE 114 Key Information - Novartis AG
- TABLE 115 Key Information - Biogen, Inc.
- TABLE 116 Key Information - Amgen, Inc.
